Andrew Ashe

Andrew Ashe

President at VERVE THERAPEUTICS, INC.

Net worth: 4 M $ as of 31/03/2024

57 year
Health Technology
Commercial Services
Consumer Services

Profile

Andrew D.
Ashe
is currently the President, COO & General Counsel at Verve Therapeutics, Inc. Prior to his current position, he held the role of General Counsel at Beacon Therapeutics (USA), Inc. from 2017 to 2018.
Before that, he served as Secretary, Executive VP & General Counsel at Dyax Corp.
from 2015 to 2016.
Additionally, Mr. Ashe was a Member-Business Law Practices at Nutter McClennen & Fish LLP and Prince Lobel Tye LLP.
He obtained his undergraduate degree from the University of Massachusetts and his graduate degree from George Washington University Law School.
He also holds an undergraduate degree from The Isenberg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/02/2024 266,509 ( 0.34% ) 4 M $ 31/03/2024

Andrew Ashe active positions

CompaniesPositionStart
VERVE THERAPEUTICS, INC. President 01/08/2018
All active positions of Andrew Ashe

Former positions of Andrew Ashe

CompaniesPositionEnd
APPLIED GENETIC TECHNOLOGIES CORPORATION General Counsel 01/08/2018
DYAX CORP. Chief Administrative Officer 01/01/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Andrew Ashe's experience

Training of Andrew Ashe

The Isenberg School of Management Undergraduate Degree
George Washington University Law School Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Ashe's experience

Connections

59

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
VERVE THERAPEUTICS, INC.

Health Technology

Private companies4

Health Technology

Commercial Services

Health Technology

Commercial Services

See company connections